Human Milk Feeding and Preterm Infants' Growth and Body Composition: A Literature Review

Jacopo Cerasani1, Federica Ceroni1, Valentina De Cosmi1,2

  • 1Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.

Nutrients
|April 25, 2020
PubMed

Insights

Human milk feeding in preterm infants promotes better body composition and fat-free mass deposition, potentially improving metabolic and neurodevelopmental outcomes despite slower initial weight gain.

Area of Science:

  • Neonatal nutrition and development
  • Pediatric health outcomes
  • Human milk research

Background:

  • Preterm infants face elevated risks for metabolic syndrome and cognitive impairment.
  • Nutrition, body composition, and early growth are critical for long-term health programming.
  • Postnatal growth retardation and abnormal body composition at discharge remain significant challenges.

Purpose of the Study:

  • To review the impact of human milk feeding on body composition and growth in preterm infants.
  • To update current understanding of human milk's role in mitigating adverse health outcomes.
  • To emphasize the importance of human milk for preterm infant care.

Main Methods:

  • Literature review on human milk feeding in preterm infants.
  • Analysis of studies focusing on nutrition, body composition, and growth.
  • Synthesis of evidence regarding metabolic and neurodevelopmental effects.

Main Results:

  • Human milk feeding is associated with slower initial weight gain compared to formula.
  • It promotes better recovery of body composition by increasing fat-free mass deposition.
  • This improved composition may lead to enhanced metabolic and neurodevelopmental outcomes.

Conclusions:

  • Human milk feeding supports favorable body composition in preterm infants.
  • It is a crucial strategy for improving long-term health outcomes.
  • Prioritizing human milk promotion and support is essential in preterm infant care.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
86.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
174